SEALSQ Corp. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, dated March 4, 2024, reports financing activity completed by SEALSQ Corp. during March 2024. The company is a British Virgin Islands foreign private issuer listed on Nasdaq and files annual reports on Form 20-F.
Financing and Key Financial Metrics
- On March 1, 2024, SEALSQ closed a third financing tranche with aggregate principal of $10.0 million.
- The financing consists of 2.5% senior original issue discount convertible notes due 2026. The 2.5% discount results in approximately $9.75 million of proceeds before expenses.
- The notes are convertible at the lesser of $5.50 per ordinary share or 93% of the lowest volume-weighted average price during the preceding 10 trading days, subject to a $0.55 floor that may be reduced by mutual consent.
- Investors also received five-year warrants to purchase 1,537,358 ordinary shares at an exercise price of $5.50 per share. Cashless exercise is available after six months if the applicable resale registration statement is not effective.
- The filing does not provide revenue, operating profit, net income, cash flow, margins, total liquidity, or a complete debt balance for the reporting period.
- Including the previously disclosed first and second tranches, the transaction program has involved up to $30.0 million of note principal, before any conversions and excluding potential future tranches.
Material Changes Versus Prior Comparable Financing
- The third tranche uses a 2.5% original issue discount, compared with 4% original issue discounts for the first and second tranches.
- The fixed conversion and warrant exercise price for the third tranche was increased from $4.00 to $5.50, while the variable conversion price remains subject to a $0.55 floor.
- Investors agreed to commercially reasonable efforts to limit weekly sales of third-tranche conversion shares and warrant shares to 10% of average weekly trading volume, subject to exceptions.
- As of the filing, investors had converted all first-tranche notes into 9,717,438 ordinary shares and had converted $5.1 million of second-tranche notes into 3,069,970 ordinary shares.
- The company reported 20,297,092 ordinary shares outstanding as of the filing date. Additional conversions and warrant exercises could materially increase the share count.
Outlook, Risks, Contingencies, and Unusual Items
- Fourth and fifth tranches may be issued, subject to mutual consent and other closing conditions, with up to $10.0 million of additional principal in each tranche.
- The company must file a registration statement covering third-tranche conversion shares and warrant shares within 30 trading days after the March 1 closing and intends to have it declared effective as soon as practicable.
- Registration statements for any fourth or fifth tranche securities would be due within 20 trading days after the applicable closing.
- The company agreed to maintain a reserve of 40 million ordinary shares for third-tranche obligations.
- Investors waived, solely for the third tranche, certain restrictions on additional indebtedness. The waiver permits specified indebtedness, including up to $2.0 million payable to Cisco Systems and certain affiliate loans subject to stated limits.
- The notes contain variable-price conversion and anti-dilution provisions, creating potential dilution and possible downward pressure on the ordinary share price.
- The filing does not provide management guidance regarding revenue, earnings, cash flow, or operating performance.
Investor Verification Checklist
- Verify the final terms, maturity, interest, default provisions, and conversion mechanics in the executed third-tranche note.
- Monitor the effectiveness and timing of the third-tranche resale registration statement.
- Reconcile subsequent conversions, warrant exercises, and the resulting fully diluted share count.
- Assess whether fourth and fifth tranches are completed and their impact on debt, liquidity, and dilution.
- Review the company’s next periodic filing for actual cash proceeds, financing costs, outstanding debt, liquidity, and any required derivative or conversion-accounting adjustments.